Article

Saettele leads WaveLight subsidiary

Sterling, VA-Ralph Saettele will succeed Wade S. Tetsuka as president of U.S. operations for WaveLight Inc.'s U.S. subsidiary.

Sterling, VA-Ralph Saettele will succeed Wade S. Tetsuka as president of U.S. operations for WaveLight Inc.'s U.S. subsidiary.

Saettele had been assistant to the chief executive officer, Max Reindl, and has been responsible for business development in the company's ophthalmology division. The German company established a foot-hold in the U.S. market 3 years ago, and has witnessed "significant growth."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
© 2025 MJH Life Sciences

All rights reserved.